Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 25.44% is 19% below its 5-year average of 31.49%, near the low end of its 5-year range (25.44%–40.92%).
As of the fiscal period ended Sunday, April 5, 2026. 4.40% below its 12-month average of 26.61%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
25.44%
EBITDA MARGIN AVG TTM
26.61%
EBITDA MARGIN AVG 3Y
28.66%
EBITDA MARGIN AVG 5Y
31.49%
EBITDA MARGIN AVG 10Y
27.38%
EBITDA MARGIN AVG 15Y
23.43%
EBITDA MARGIN AVG 20Y
21.31%
CURRENT VS TTM AVG
-4.40%
CURRENT VS 3Y AVG
-11.23%
CURRENT VS 5Y AVG
-19.21%
CURRENT VS 10Y AVG
-7.07%
CURRENT VS 15Y AVG
+8.61%
CURRENT VS 20Y AVG
+19.41%
Market Cap
$12.11B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
Market Cap
$13.51B
EBITDA Margin
5.99%
TTM Avg
7.75%
3Y Avg
3.55%
5Y Avg
8.89%
Market Cap
$11.29B
EBITDA Margin
17.40%
TTM Avg
22.43%
3Y Avg
29.14%
5Y Avg
30.66%
Market Cap
$11.20B
EBITDA Margin
22.69%
TTM Avg
18.62%
3Y Avg
20.95%
5Y Avg
21.80%
Market Cap
$14.10B
EBITDA Margin
27.02%
TTM Avg
27.38%
3Y Avg
26.41%
5Y Avg
26.36%
Market Cap
$10.37B
EBITDA Margin
-7.87%
TTM Avg
-5.60%
3Y Avg
-1.35%
5Y Avg
0.44%
Market Cap
$14.80B
EBITDA Margin
32.07%
TTM Avg
25.68%
3Y Avg
26.69%
5Y Avg
27.49%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revvity, Inc. (RVTY) | $12.55B | 25.44% | 26.61% | 28.66% | 31.49% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 19.75% | 19.29% | 19.87% | 21.06% |
| Baxter International Inc. (BAX)vs › | $13.51B | 5.99% | 7.75% | 3.55% | 8.89% |
| Insulet Corp. (PODD)vs › | $11.45B | 21.67% | 20.24% | 16.36% | 15.66% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 17.40% | 22.43% | 29.14% | 30.66% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.20B | 22.69% | 18.62% | 20.95% | 21.80% |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 27.02% | 27.38% | 26.41% | 26.36% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -7.87% | -5.60% | -1.35% | 0.44% |
| Solventum Corporation (SOLV)vs › | $14.80B | 32.07% | 25.68% | 26.69% | 27.49% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 2.15% | 3.41% | 4.20% | 4.49% |
Gross Margin
51.4%
EBITDA Margin
25.4%
Operating Margin
12.4%
Net Margin
8.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-04-05 | 25.44% |
| 2025-12-28 | 27.83% |
| 2025-09-28 | 26.32% |
| 2025-06-29 | 26.87% |
| 2025-03-30 | 25.52% |
| 2024-12-29 | 32.54% |
| 2024-09-29 | 30.74% |
| 2024-06-30 | 30.18% |
| 2024-03-31 | 27.99% |
| 2023-12-31 | 29.45% |
| 2023-09-30 | 30.04% |
| 2023-06-30 | 31.03% |
| 2023-04-02 | 30.35% |
| 2022-12-31 | 34.40% |
| 2022-10-02 | 28.55% |
| 2022-06-30 | 39.54% |
| 2022-03-31 | 40.47% |
| 2021-12-31 | 40.92% |
| 2021-09-30 | 37.17% |
| 2021-06-30 | 34.52% |
| 2021-03-31 | 41.93% |
| 2020-12-31 | 43.25% |
| 2020-09-30 | 32.37% |
| 2020-06-30 | 28.73% |
| 2020-03-31 | 20.91% |
| 2019-12-31 | 25.02% |
| 2019-09-30 | 21.06% |
| 2019-06-30 | 21.12% |
| 2019-03-31 | 18.24% |
| 2018-12-31 | 23.17% |
| 2018-09-30 | 20.88% |
| 2018-06-30 | 20.30% |
| 2018-03-31 | 15.20% |
| 2017-12-31 | 13.22% |
| 2017-09-30 | 25.35% |
| 2017-06-30 | 19.11% |
| 2017-03-31 | 17.39% |
| 2016-12-31 | 19.87% |
| 2016-09-30 | 20.47% |
| 2016-06-30 | 17.76% |
| 2016-03-31 | 17.54% |
| 2015-12-31 | 19.94% |
| 2015-09-30 | 17.90% |
| 2015-06-30 | 17.70% |
| 2015-03-31 | 16.26% |
| 2014-12-31 | 9.70% |
| 2014-09-30 | 17.85% |
| 2014-06-30 | 17.81% |
| 2014-03-31 | 15.09% |
| 2013-12-31 | 20.46% |
| 2013-09-30 | 17.42% |
| 2013-06-30 | 14.60% |
| 2013-03-31 | 13.74% |
| 2012-12-31 | 13.83% |
| 2012-09-30 | 16.40% |
| 2012-06-30 | 16.73% |
| 2012-03-31 | 14.63% |
| 2011-12-31 | 4.80% |
| 2011-09-30 | 13.86% |
| 2011-06-30 | 14.17% |
| 2011-03-31 | 14.20% |
| 2010-12-31 | 17.24% |
| 2010-09-30 | 14.07% |
| 2010-06-30 | 15.58% |
| 2010-03-31 | 13.59% |
| 2009-12-31 | 16.37% |
| 2009-09-30 | 14.21% |
| 2009-06-30 | 13.90% |
| 2009-03-31 | 12.89% |
| 2008-12-31 | 25.00% |
| 2008-09-30 | 12.47% |
| 2008-06-30 | 13.16% |
| 2008-03-31 | 12.25% |
| 2007-12-31 | 17.01% |
| 2007-09-30 | 14.85% |
| 2007-06-30 | 14.34% |
| 2007-03-31 | 14.22% |
| 2006-12-31 | 15.83% |
| 2006-09-30 | 13.87% |
| 2006-06-30 | 13.94% |
| 2006-03-31 | 13.06% |
| 2005-12-31 | 47.90% |
| 2005-09-30 | 15.07% |
| 2005-06-30 | 18.80% |
| 2005-03-31 | 13.46% |
| 2004-12-31 | 19.28% |
| 2004-09-30 | 15.23% |
| 2004-06-30 | 14.42% |
| 2004-03-31 | 13.01% |
| 2003-12-31 | 30.58% |
| 2003-09-30 | 15.10% |
| 2003-06-30 | 12.47% |
| 2003-03-31 | 14.87% |
| 2002-12-31 | 22.93% |
| 2002-09-30 | 13.38% |
| 2002-06-30 | 12.23% |
